Request Deal Involvement
Dawn Biopharma led a €16m Series A extension round in Adcendo.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Optimum Strategic Communications
legal advisors
Gorrissen Federspiel
or
Principals
target
ADCENDO APS
bidder
DAWN BIOPHARMA
bidder
NOVO HOLDINGS A/S
bidder
YSIOS CAPITAL
bidder
RA CAPITAL MANAGEMENT
bidder
HEALTHCAP
bidder
GILDE HEALTHCARE
bidder
PONTIFAX VENTURE CAPITAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite